asa guidelines for glp 1 drugs 2025 asa guidelines glp 1 April 2024 Infographic in Anesthesiology-bsmoothhr 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations

Rotate injection sites between abdomen, thigh, and upper arm to minimize reactions

Patients may experience side effects such as gastrointestinal discomfort, and certain populations, such as those with pancreatitis or severe gastrointestinal disorders, may not be suitable candidates

They are more proactively involved in managing their condition and open to therapies that can help achieve optimal glucose control safely

The phase II obesity study of retatrutide also included a MASH substudy to assess its effects on the amount of liver fat

Here, we mainly summarize the relevant experiments on the SMG treatment effect in people with obesity (STEP) programs